WhiteBook2_Part2 - 15

Results
EU trials/epidemiological studies/networks/surveys and primary prevention were, on
average, the most highly ranked research areas in terms of feasibility to conduct (Figure 6).
EU trials/epidemiological studies/networks/surveys was ranked higher than biobanking/
surveillance by 22 out of 33 societies. Furthermore, primary prevention was ranked most
feasible by 8 societies (24%) (Figure 7). Biomarkers/profiling/genetics and medical training
were each ranked most feasible by 5 societies (15%). EU trials/epidemiological studies/
networks/surveys was ranked most feasible by 4 societies (12%).
Figure 6.
Average rankings of research areas in terms of feasibility to conduct
EU trials/epidemiological studies/networks/surveys
Life−style/nutrition/diet/obesity
Primary prevention
Hi−tech imaging/artificial intelligence
Microbiota−host interaction/immunity
Biomarkers/profiling/genetics
Medical training
Gut−brain interaction/enteric nervous system/neural controls
Precision/personalised medicine
Biobanking/surveillance
Source: authors' compilation using sur vey data from UEG national society members .
Note: Lower mean rank values indicate more preferred research areas.
2
Mean rank
4
6
Figure 7.
Proportion of societies that ranked each research area as most feasible
Primary prevention
Biomarkers/profiling/genetics
Medical training
EU trials/epidemiological studies/networks/surveys
Hi−tech imaging/artificial intelligence
Life−style/nutrition/diet/obesity
Microbiota−host interaction/immunity
Precision/personalised medicine
Biobanking/surveillance
Gut−brain interaction/enteric nervous system/neural controls
Source: authors' compilation using sur vey data from UEG national society members .
White Book 2: Part 2
12

WhiteBook2_Part2

Table of Contents for the Digital Edition of WhiteBook2_Part2